Echo Therapeutics Starts Clinical Study Of Glucose Monitoring System

Echo Therapeutics has started the second clinical study of its current Symphony Continuous Transdermal Glucose Monitoring System (CTGM System).

This entry was posted on Friday, January 4th, 2008 at 10:10 am and is filed under General. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.